EGFR exon 20 Insertion NSCLC and Response to Platinum-Based Chemotherapy von Shah, Manan P., Aredo, Jacqueline V., Padda, Sukhmani K., Ramchandran, Kavitha J., Wakelee, Heather A., Das, Millie S., Neal, Joel W.

Volltext

Pulmonary Hemorrhage in Patients Treated With Thoracic Stereotactic Ablative Radiotherapy and Antiangiogenic Agents von Lau, Brianna C., Wu, Yufan F., No, Hyunsoo J., Ko, Ryan B., Devine, Max D., Das, Millie S., Neal, Joel W., Wakelee, Heather A., Ramchandran, Kavitha, Gensheimer, Michael F., Diehn, Maximilian, Chin, Alexander L., Loo, Billy W., Vitzthum, Lucas K.

Volltext

Phase II Study of Immunotherapy With Tecemotide and Bevacizumab After Chemoradiation in Patients With Unresectable Stage III Non-Squamous Non–Small-Cell Lung Cancer (NS-NSCLC): A T... von Patel, Jyoti D., Lee, Ju-Whei, Carbone, David P., Wagner, Henry, Shanker, Anil, de Aquino, Maria Teresa P., Horn, Leora, Johnson, Melissa L., Gerber, David E., Liu, Jane Jijun, Das, Millie S., Al-Nsour, Mohammed Ali, Dakhil, Christopher S.R., Ramalingam, Suresh, Schiller, Joan H.

Volltext

Are We Getting Closer to the Promise of Cure? New Progress and Future Directions in the Treatment of Early-Stage Non-Small-Cell Lung Cancer von Das, Millie

Volltext

Systemic Therapy of Extensive Stage Small Cell Lung Cancer in the Era of Immunotherapy von Ragavan, Meera, Das, Millie

Volltext

Understanding the barriers and experiences of veterans with lung cancer von Lopez, Christopher, Murillo, Ariana, Das, Millie, Patel, Manali I.

Volltext

ERBB2-Mutated Metastatic Non–Small Cell Lung Cancer: Response and Resistance to Targeted Therapies von Chuang, Jody C., Stehr, Henning, Liang, Ying, Das, Millie, Huang, Jane, Diehn, Maximilian, Wakelee, Heather A., Neal, Joel W.

Volltext

A New Drug Discovery Platform: Application to DNA Polymerase Eta and Apurinic/Apyrimidinic Endonuclease 1 von Das, Debanu, Duncton, Matthew A J, Georgiadis, Taxiarchis M, Pellicena, Patricia, Clark, Jennifer, Sobol, Robert W, Georgiadis, Millie M, King-Underwood, John, Jobes, David V, Chang, Caleb, Gao, Yang, Deacon, Ashley M, Wilson, 3rd, David M

Volltext

Impact of KEAP1/NFE2L2/CUL3 mutations on duration of response to EGFR tyrosine kinase inhibitors in EGFR mutated non-small cell lung cancer von Hellyer, Jessica A., Stehr, Henning, Das, Millie, Padda, Sukhmani K., Ramchandran, Kavitha, Neal, Joel W., Diehn, Maximilian, Wakelee, Heather A.

Volltext

ROS1-rearranged non-small cell lung cancer: Understanding biology and optimizing management in the era of new approvals von Myall, Nathaniel J, Das, Millie

Volltext

Small Cell Lung Cancer: Emerging Targets and Strategies for Precision Therapy von Patel, Shruti R, Das, Millie

Volltext

Role of KEAP1/NFE2L2 Mutations in the Chemotherapeutic Response of Patients with Non-Small Cell Lung Cancer von Jeong, Youngtae, Hellyer, Jessica A., Stehr, Henning, Hoang, Ngoc T., Niu, Xiaomin, Das, Millie, Padda, Sukhmani K., Ramchandran, Kavitha, Neal, Joel W., Wakelee, Heather, Diehn, Maximilian

Volltext

Novel immunotherapy combinations in neoadjuvant non-small cell lung cancer (NSCLC): a better chance at cure? von Salter, Alexander I., Das, Millie

Volltext

Noninvasive Early Identification of Therapeutic Benefit from Immune Checkpoint Inhibition von Nabet, Barzin Y., Esfahani, Mohammad S., Moding, Everett J., Hamilton, Emily G., Chabon, Jacob J., Rizvi, Hira, Steen, Chloe B., Chaudhuri, Aadel A., Liu, Chih Long, Hui, Angela B., Almanza, Diego, Stehr, Henning, Gojenola, Linda, Bonilla, Rene F., Jin, Michael C., Jeon, Young-Jun, Tseng, Diane, Liu, Cailian, Merghoub, Taha, Neal, Joel W., Wakelee, Heather A., Padda, Sukhmani K., Ramchandran, Kavitha J., Das, Millie, Plodkowski, Andrew J., Yoo, Christopher, Chen, Emily L., Ko, Ryan B., Newman, Aaron M., Hellmann, Matthew D., Alizadeh, Ash A., Diehn, Maximilian

Volltext

Advances in Treatment of Recurrent Small Cell Lung Cancer (SCLC): Insights for Optimizing Patient Outcomes from an Expert Roundtable Discussion von Das, Millie, Padda, Sukhmani K., Weiss, Jared, Owonikoko, Taofeek K.

Volltext

Fragment- and structure-based drug discovery for developing therapeutic agents targeting the DNA Damage Response von Wilson, David M., Deacon, Ashley M., Duncton, Matthew A.J., Pellicena, Patricia, Georgiadis, Millie M., Yeh, Andrew P., Arvai, Andrew S., Moiani, Davide, Tainer, John A., Das, Debanu

Volltext

Role of Consolidation Durvalumab in Patients With EGFR- and HER2-Mutant Unresectable Stage III NSCLC von Hellyer, Jessica A., Aredo, Jacqueline V., Das, Millie, Ramchandran, Kavitha, Padda, Sukhmani K., Neal, Joel W., Wakelee, Heather A.

Volltext

The Crystal Structure of the Monomeric Reverse Transcriptase from Moloney Murine Leukemia Virus von Das, Debanu, Georgiadis, Millie M

Volltext

Development of a DNA damage response (DDR) therapeutics platform for oncology von Das, Debanu, Duncton, Matthew, Pellicena, Patricia, Deacon, Ashley, Wilson, David, Georgiadis, Millie

Volltext

Pharmacovigilance Analysis of Cardiac Toxicities Associated With Targeted Therapies for Metastatic NSCLC von Waliany, Sarah, Zhu, Han, Wakelee, Heather, Padda, Sukhmani K., Das, Millie, Ramchandran, Kavitha, Myall, Nathaniel J., Chen, Thomas, Witteles, Ronald M., Neal, Joel W.

Volltext